Skip to main content
. Author manuscript; available in PMC: 2022 Jun 9.
Published in final edited form as: Nano Lett. 2021 May 24;21(11):4692–4699. doi: 10.1021/acs.nanolett.1c00895

Figure 3.

Figure 3.

Monitoring of 90Y-DOTA-UPSN. (A) Long-term Cerenkov luminescence imaging of mice injected with 90Y-DOTA-UPSN demonstrated tumor accumulation throughout a therapeutic study. (B) Ex vivo CLI of major organs confirmed high tumor uptake relative to other tissues. (C) Quantitave data of radiant efficiency of major organs calculated from ex vivo CLI. *Significantly higher (p < 0.05) than all the others investigated (n = 5).